1. Home
  2. OPTN vs STRW Comparison

OPTN vs STRW Comparison

Compare OPTN & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTN
  • STRW
  • Stock Information
  • Founded
  • OPTN 2010
  • STRW 2015
  • Country
  • OPTN United States
  • STRW United States
  • Employees
  • OPTN N/A
  • STRW N/A
  • Industry
  • OPTN Biotechnology: Pharmaceutical Preparations
  • STRW Real Estate Investment Trusts
  • Sector
  • OPTN Health Care
  • STRW Real Estate
  • Exchange
  • OPTN Nasdaq
  • STRW Nasdaq
  • Market Cap
  • OPTN 78.4M
  • STRW 92.9M
  • IPO Year
  • OPTN 2017
  • STRW N/A
  • Fundamental
  • Price
  • OPTN $0.45
  • STRW $10.51
  • Analyst Decision
  • OPTN Strong Buy
  • STRW Strong Buy
  • Analyst Count
  • OPTN 3
  • STRW 1
  • Target Price
  • OPTN $3.00
  • STRW $10.00
  • AVG Volume (30 Days)
  • OPTN 1.2M
  • STRW 216.7K
  • Earning Date
  • OPTN 11-12-2024
  • STRW 11-08-2024
  • Dividend Yield
  • OPTN N/A
  • STRW 5.04%
  • EPS Growth
  • OPTN N/A
  • STRW 23.40
  • EPS
  • OPTN N/A
  • STRW 0.51
  • Revenue
  • OPTN $75,672,000.00
  • STRW $112,050,000.00
  • Revenue This Year
  • OPTN $13.42
  • STRW N/A
  • Revenue Next Year
  • OPTN $52.99
  • STRW N/A
  • P/E Ratio
  • OPTN N/A
  • STRW $20.26
  • Revenue Growth
  • OPTN 5.13
  • STRW 14.46
  • 52 Week Low
  • OPTN $0.32
  • STRW $6.56
  • 52 Week High
  • OPTN $2.10
  • STRW $12.90
  • Technical
  • Relative Strength Index (RSI)
  • OPTN 39.55
  • STRW 42.39
  • Support Level
  • OPTN $0.42
  • STRW $10.06
  • Resistance Level
  • OPTN $0.57
  • STRW $10.55
  • Average True Range (ATR)
  • OPTN 0.05
  • STRW 0.63
  • MACD
  • OPTN 0.00
  • STRW -0.07
  • Stochastic Oscillator
  • OPTN 26.39
  • STRW 37.14

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

About STRW Strawberry Fields REIT Inc.

Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.

Share on Social Networks: